Aurora Spine Celebrates Significant Milestone
Aurora Spine Corporation, recognized for its commitment to innovative spinal solutions, is thrilled to announce an exciting achievement: the successful application of its DEXA-C™ spinal implant system in over 1,500 surgeries across the United States. This pivotal moment highlights not only the profound trust in the DEXA Technology™ platform but also its relentless integration into the spinal care community.
Revolutionary DEXA Technology™
The DEXA Technology™ is pioneering in the world of spinal implants. It's the first platform intentionally designed to address varying bone densities, specifically for patients with conditions like osteoporosis. With its open porous structure, the DEXA-C™ implant promotes the essential processes of osseointegration and vascularization, mimicking the natural architecture of human bone. This innovation results in enhanced performance in surgeries, promising better outcomes for individuals with diverse spinal needs.
Insights from Leadership
Trent Northcutt, the President and CEO of Aurora Spine, expressed immense pride in this milestone. “The DEXA-C™ system provides surgeons with an unparalleled tool, placing bone quality at the forefront of implant selection,” he noted. With a robust data set affirming improved outcomes, Aurora Spine is poised to expand its efforts in marketing this breakthrough technology. In line with this initiative, the company is preparing to launch DEXA-L™, a standalone Anterior Lumbar Interbody Fusion system, anticipated to debut in the near future.
Addressing Diverse Patient Needs
The launch of DEXA-L™ aligns with Aurora's mission to enhance the lives of patients requiring spinal interventions. Traditionally, the spinal implant industry has catered primarily to individuals with healthy bone density. Unfortunately, this has left a gap in performance for patients suffering from lower bone density. DEXA Technology™ stands out as a reliable, density-matched solution that thoughtfully addresses these gaps.
A Comprehensive Portfolio
Continuing its journey towards revolutionizing spine care, Aurora Spine boasts an expanding portfolio that now includes systems for cervical, lumbar, and sacroiliac fusion. The company’s commitment to personalized spine solutions is unwavering, and the DEXA line exemplifies its innovative approach.
Looking Ahead
As Aurora Spine looks to the future, its concentration remains firmly on enhancing surgical outcomes and ensuring patient safety and satisfaction. With the exciting introduction of the DEXA-L™ system, the company is better equipped to serve a broader patient demographic and to facilitate effective spinal fusions for even the most complex cases.
Company Overview
Aurora Spine continues to lead the charge in spinal implant technology, prioritizing minimally invasive and regenerative methods that cater to the diverse needs of patients. More insights into Aurora's innovative products can be found on their official website.
Company Contacts
Trent Northcutt
President and Chief Executive Officer
(760) 424-2004
Chad Clouse
Chief Financial Officer
(760) 424-2004
Frequently Asked Questions
What is the DEXA-C™ system?
The DEXA-C™ system is an advanced spinal implant technology designed to match patients' bone densities, ensuring better outcomes in surgeries.
How many surgeries have been performed using DEXA-C™?
Over 1,500 successful surgeries have utilized the DEXA-C™ system, marking a significant achievement for Aurora Spine.
What industry recognition has Aurora Spine received?
Aurora Spine was honored with the Best Technology in Spine Award for its DEXA Technology™ platform, showcasing its commitment to innovation.
What is the upcoming product from Aurora Spine?
Aurora Spine is preparing to launch the DEXA-L™, a new implant system designed specifically for Anterior Lumbar Interbody Fusion (ALIF) procedures.
How does the DEXA Technology™ differ from traditional spinal implants?
Unlike traditional implants that primarily serve patients with healthy bone, DEXA Technology™ is specifically designed for a broader spectrum of bone densities, including osteoporotic patients.
